News · Heart & Metabolic
A newer heart rhythm ablation method carried a higher 30-day stroke risk than the older one
Pulsed field ablation spread fast on the promise of being safer than burning tissue. A single-center registry comparing it against radiofrequency found more strokes and mini-strokes at 30 days.
- Strokes and mini-strokes within 30 days were about 0.47% with the newer method against 0.10%.
- The absolute difference is small; the relative difference is not.
- Events were spread across the study period, not clustered while operators learned.
- Procedures with the newer method were shorter and treated more tissue.
- One high-volume center, and the total number of events was very small.
New medical technology usually arrives with a specific safety claim, and pulsed field ablation arrived with a good one. Instead of burning or freezing the heart tissue that generates an abnormal rhythm, it kills it with short electrical pulses that act preferentially on heart muscle.
That selectivity spares the esophagus and the nerve to the diaphragm, both of which thermal methods occasionally damage badly. The argument was sound, the adoption was rapid, and the procedure is now performed in enormous numbers.
A safety claim about one set of injuries is not a safety claim about all of them.
The comparison
Writing in Circulation, investigators at a single high-volume center compared the two approaches in their own registry, weighting the groups so that the patients being compared were alike on the characteristics that predict stroke.
Previously the comparative safety data between the two modalities had remained limited, which is an uncomfortable thing to be true of a technique already in widespread use.
What they found
Strokes and mini-strokes within thirty days were more common after the newer method: ten events against two.
In percentage terms that is about 0.47% against about 0.10%. In absolute terms it is roughly one extra event for every 270 procedures.
Both framings are honest and they land very differently. A patient facing one procedure is being told about a rare event that became slightly less rare. A health system performing thousands is being told about a real number of strokes.
Ruling out the obvious explanation
The first thing anyone would say is that operators were learning. New technique, unfamiliar catheter, early cases.
The authors checked, and events were evenly distributed throughout the study period with no clustering around the time of adoption, and no operator accounted for more than one. That does not eliminate a learning effect, but it argues against the simplest version of it.
They also tested whether the newer procedures simply treated more tissue, since they more often included isolation of the back wall of the atrium. The mediation models could not confirm that, and the authors are explicit that the low event count limited what those models could show.
So the mechanism is unexplained, which is where a finding like this usually sits before anyone chases it properly.
What one center cannot establish
Twelve events in total. That is the number carrying the entire result, and small event counts produce unstable estimates however carefully the groups are balanced.
It is also a registry at one hospital rather than a randomized comparison. Weighting can balance the characteristics that were recorded and can do nothing about the reasons an operator chose one method for a particular patient.
The reasonable reading
If you have AFib, your heart beats irregularly and sometimes much faster than normal, and ablation is a well-established way of addressing that.
Nothing here argues against the procedure or against the newer method, which remains safer for the injuries it was designed to avoid. What it argues for is the unglamorous thing the authors ask for: proper post-market surveillance of a technique that reached very high volumes on the strength of a safety claim that was true about something else.
People also ask
What did the study find?
The 30-day rate of stroke or transient ischemic attack was significantly higher for pulsed field ablation (10 events; 0.47%) than radiofrequency ablation (2 events; 0.10%) in both unweighted and propensity score-weighted analyses (weighted risk difference 0.36%; 95% CI, 0.03%-0.70%; P = 0.03). Procedures were shorter with pulsed field ablation (108 versus 144 minutes) and included more frequent posterior wall isolation (57% versus 31%).
What is pulsed field ablation?
A method that uses short electrical pulses to kill heart tissue causing an abnormal rhythm, rather than heating or freezing it. Its main selling point is that it targets heart muscle preferentially, sparing the esophagus and nerves that thermal methods can injure.
So why would it cause more strokes?
The study cannot say. It tested whether treating more tissue explained it and could not confirm that, partly because there were too few events to model. The mechanism remains open.
How large is the risk in absolute terms?
Small. Roughly one extra event for every 270 procedures, on these figures. That matters differently to a health system weighing thousands of procedures than to an individual weighing one.
Could this be operators learning a new technique?
The authors checked. Events were evenly distributed across the study period rather than clustered around the time the method was adopted, and no single operator accounted for more than one, which argues against a pure learning-curve explanation.
Does this mean the newer method is worse?
No. It is safer than thermal ablation for the injuries thermal ablation causes, which is why it spread. This identifies a different risk that appears to run the other way, and both belong in the comparison.
What should a patient scheduled for ablation do?
Ask which method is planned and why, since the trade-offs differ and a cardiologist can weigh them against an individual history. This is general information rather than medical advice.